The U.S. Food and Drug Administration said on Friday it approved new labeling for Sarepta Therapeutics' gene therapy Elevidys ...

Routine liver function tests (LFTs) typically comprise alanine aminotransferase (ALT), alkaline phosphatase (ALP), bilirubin, ...

The two appeared in court for the first time since being charged in the Fayette County child's death. Eleven witnesses ...

The agency is cautioning patients about the risk of serious, possibly fatal, liver injuries and has limited the gene therapy's use to ambulatory patients.

India faces a massive diabetes surge. On World Diabetes Day 2025, Dr. Saptarshi Bhattacharya explains how genetics, lifestyle ...

Investing.com -- Sarepta Therapeutics (NASDAQ:SRPT) stock rose 7% after the U.S. Food and Drug Administration approved new labeling for its gene therapy Elevidys that includes a Boxed Warning and ...

In both fatal cases, patients developed markedly elevated liver enzymes and required hospitalization within two months of Elevidys infusion. An additional serious, non-fatal case of acute liver injury ...

India’s battle against diabetes is entering a new phase as diagnostic data and clinical experts warn of a marked rise in the ...

The Imota LCDA’s health screening program underscores a growing recognition of workplace wellness as a key pillar of ...

The Food and Drug Administration is adding a new warning to a gene therapy linked to two patient deaths earlier this year.

The ancient spice that reduces bloating - and could boost weight loss - A diet high in antioxidants can help reduce the risk ...

Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results and provided a business update for the three and nine ...